LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro

被引：0
|
作者：
Ping Xiao
Lin-lin Sun
Jing Wang
Rui-li Han
Qing Ma
Dian-sheng Zhong
机构：
[1] Tianjin Medical University General Hospital,Department of Oncology
[2] Tianjin Lung Cancer Institute,undefined
[3] Tianjin Medical University General Hospital,undefined
来源：
Acta Pharmacologica Sinica | 2015年 / 36卷
关键词：
non small-cell lung cancer; mTOR protein; liver kinase B1; AKT; rapamycin; RAD001; LY294002;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1107 / 1112
页数：5
相关论文
共 50 条
  • [31] PREDICTIVE VALUE OF LKB1 IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER
    Fabre, E.
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Blons, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [32] Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer
    Liu, Yan
    Cowley, Glenn S.
    Cohoon, Travis J.
    Root, David E.
    Kwok-kin, Wong
    CANCER RESEARCH, 2012, 72
  • [33] The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
    Mograbi, Baharia
    Heeke, Simon
    Hofman, Paul
    DIAGNOSTICS, 2021, 11 (02)
  • [34] Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK
    Liu, Y.
    Li, H.
    Li, L. -H.
    Tang, J. -B.
    Sheng, Y. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 : 274 - 280
  • [35] LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small cell lung cancer (NSCLC) cells
    Whang, Young M.
    Park, Serk I.
    Trenary, Irina A.
    Lee, Changki
    Kaufman, Jacob M.
    Carbone, David P.
    Young, Jamey D.
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Phenformin combines with selumetinib in targeting KRAS mutant non-small cell lung cancer cells with alternative LKB1 status.
    Zhang, Jun
    Wang, Dongsheng
    Qian, Guoqing
    Liu, Fakeng
    Rahman, Mohammad Aminur
    Nannapaneni, Sreevinas
    Wang, Xu
    Peng, Xianghong
    Chen, Zhuo Georgia
    Wong, Kwok-Kin
    Khuri, Fadlo Raja
    Zhou, Wei
    Shin, Dong Moon
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] LOSS OF LKB1 IS ASSOCIATED WITH RESISTANCE TO IFN-GAMMA AND T CELL KILLING IN NON-SMALL CELL LUNG CANCER
    Reuben, Alexandre
    Jiang, Peixin
    Nie, Hui
    Cobo, Ana Galan
    Dang, Minghao
    Qian, Yu
    Frank, Meredith
    Blitz, Emily
    Hamdi, Haifa
    Denning, Warren
    Nilsson, Monique
    Poteete, Alissa
    Shen, Li
    Wang, Qi
    Guijarro, Irene
    Nichols, Keri
    Khairullah, Roohussaba
    Zhang, Jiexin
    Skoulidis, Ferdinandos
    Wang, Jing
    Wang, Linghua
    Heymach, John
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A960 - A960
  • [38] Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
    Borzi, Cristina
    Galli, Giulia
    Ganzinelli, Monica
    Signorelli, Diego
    Vernieri, Claudio
    Garassino, Marina Chiara
    Sozzi, Gabriella
    Moro, Massimo
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 12
  • [39] An expression quantitative trait locus variant for LKB1 gene predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer
    Seo, Hyewon
    Jung, Deuk Kju
    Kang, Hyo-Gyoung
    Jeong, Ji Yun
    Lee, Shin Yup
    Choi, Jin Eun
    Hong, Mi Jeong
    Do, Sook Kyung
    Lee, Jang Hyuck
    Lee, Won Kee
    Shin, Kyung Min
    Yoo, Seung Soo
    Lee, Jaehee
    Cha, Seung Ick
    Kim, Chang Ho
    Park, Jae Yong
    CANCER GENETICS, 2018, 228 : 73 - 82
  • [40] Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose
    Inge, Landon J.
    Coon, Keith D.
    Smith, Michael A.
    Bremner, Ross M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 137 (03): : 580 - 586
12345